Developed jointly by the Pasteur Institute of Iran and Cuba’s Finlay Vaccine Institute, the vaccine is called Soberana 02 in Cuba and Pastu Covac in Iran.

Pastu Covac is the only homegrown vaccine available for injection in children aged 2-18, he said, adding, clinical trials have shown that the vaccine is highly efficient and safe.

The vaccine prevented symptomatic disease in people inoculated with three doses by 65 percent and its effectiveness in the prevention of severe disease and hospitalization was 96.5 percent, he stated.

So far, 15 million doses of the vaccine have been produced, 8 million of which have been used in the vaccination process and the rest are ready to be delivered to the ministry, Biglari said.

He went on to say that the monthly production capacity of this vaccine is about five million doses and can be increased.

It is a conjugate vaccine with two injectable doses, which consists of the receptor-binding domain of the SARS-CoV-2 spike protein conjugated chemically to tetanus toxoid.

The two first phases of the human trial have been conducted in Cuba, while the third phase was carried out on 24,000 volunteers in Iran and 44,000 volunteers in Cuba.

It is the only vaccine in the world that can fight several mutations simultaneously, Biglari said in July.

Homegrown vaccines

Health Minister Bahram Einollahi has said five coronavirus vaccines have been so far produced domestically.

Made by researchers at the Headquarters for Executing the Order of the Imam, COVIRAN BAREKAT was unveiled on December 29, 2020, and received the license for public use on June 14.

It proved effective against Indian strain, according to Hojjat Niki-Maleki, head of the information center of Headquarters for Executing the Order of the Imam.

Eleven countries from Asia and South America, and a European country have asked for importing COVIRAN vaccine, Hassan Jalili, the vaccine’s production manager, said in June.

According to the Food and Drug Administration, 14 vaccines are being domestically developed in the country which are in different study phases.

The post Pastu Covac provides 100% immunity to omicron strain appeared first on Iran News Daily.

At the meeting, the two sides highlighted the friendly relations between Iran and Cuba as well as the joint cooperation in the field of biotechnology and genetic engineering.

Dr. Vicente explained about the cooperation between the vaccination institutes of the two countries to produce the COVID-19 vaccine and the unique features of the intended vaccine.

During the meeting, the Cuban ambassador described Zarif’s visit to his country last year as a very important start for the cooperation between the Pasteur Institute of Iran and the Cuban Finlay Institute for Vaccine for the joint production of the COVID-19 vaccine.

The Pastu Covac coronavirus vaccine, developed jointly by the Pasteur Institute and the Finlay Institute, is the only vaccine in the world that can fight several mutations simultaneously, Alireza Biglari, head of the Pasteur Institute, has said.

Due to the vaccine’s capabilities, the global demand is increasing day by day, because it is the only vaccine in the world that can fight several mutations simultaneously, he highlighted, IRIB reported on Sunday, July 25.

The third phase of the clinical trial of the vaccine is underway in eight cities. It is going to be administrated to 24,000 people by August 20. Results of the evaluation will be announced, which will help obtain sufficient documentation for the approval of the World Health Organization, Biglari said.

In previous weeks, 130,000 doses of vaccines produced in Iran and Cuba were delivered to the Ministry of Health and have been distributed in several provinces across the country, he noted.

In previous weeks, 130,000 doses of vaccines produced in Iran and Cuba were delivered to the Ministry of Health and have been distributed in several provinces across the country, he noted.

In September, the installation of the production line will be completed with a capacity of 3 million doses and will begin operation in early autumn.

The post Zarif meets with Cuba’s Finlay president to facilitate vaccine production appeared first on Iran News Daily.

Previously, preliminary results of studies show that the vaccine is 91.2 percent successful against new variants of South Africa and California, which are the worst strains of the virus, according to Biglari.

The vaccine also includes use in children aged under 18, he emphasized.

Trials in both countries are coming to an end, which has also shown good results, as well as dealing well with virus mutations.

Those who received the vaccine were totally protected from death and severe infection, he stated, adding, in addition to being available for people under the age of 18, the vaccine may activate the immune system of those who have already been infected, and it may be a reminder of other vaccines.

Due to the vaccine’s capabilities, the global demand is increasing day by day, because it is the only vaccine in the world that can fight several mutations simultaneously, he highlighted, IRIB reported on Sunday.

The third phase of the clinical trial is underway in eight cities being administrated to 24,000 people by August 20. Results of the evaluation will be announced, which will help obtain sufficient documentation for the approval of the World Health Organization, Biglari said.

In previous weeks, 130,000 doses of vaccines produced in Iran and Cuba were delivered to the Ministry of Health and have been distributed in several provinces across the country, he noted.

In September, the installation of the production line will be completed with a capacity of 3 million doses and will begin operation in early autumn.

Pastu Covac vaccine is a conjugate vaccine with two injectable doses. It consists of the receptor-binding domain of the SARS-CoV-2 spike protein conjugated chemically to tetanus toxoid.

The two first phases of the human trial have been conducted in Cuba, while the third phase is underway with 24,000 volunteers in Iran and 44,000 volunteers in Cuba.

The post Pastu Covac is world’s only vaccine targeting several mutations appeared first on Iran News Daily.